Artikel: CXCL9 GudangMovies21 Rebahinxxi

• Source: CXCL9

Chemokine (C-X-C motif) ligand 9 (CXCL9) is a small cytokine belonging to the CXC chemokine family that is also known as monokine induced by gamma interferon (MIG). The CXCL9 is one of the chemokine which plays role to induce chemotaxis, promote differentiation and multiplication of leukocytes, and cause tissue extravasation.
The CXCL9/CXCR3 receptor regulates immune cell migration, differentiation, and activation. Immune reactivity occurs through recruitment of immune cells, such as cytotoxic lymphocytes (CTLs), natural killer (NK) cells, NKT cells, and macrophages. Th1 polarization also activates the immune cells in response to IFN-γ. Tumor-infiltrating lymphocytes are a key for clinical outcomes and prediction of the response to checkpoint inhibitors. In vivo studies suggest the axis plays a tumorigenic role by increasing tumor proliferation and metastasis. CXCL9 predominantly mediates lymphocytic infiltration to the focal sites and suppresses tumor growth.
It is closely related to two other CXC chemokines called CXCL10 and CXCL11, whose genes are located near the gene for CXCL9 on human chromosome 4. CXCL9, CXCL10 and CXCL11 all elicit their chemotactic functions by interacting with the chemokine receptor CXCR3.




Biomarkers


CXCL9, -10, -11 have proven to be valid biomarkers for the development of heart failure and left ventricular dysfunction, suggesting an underlining pathophysiological relation between levels of these chemokines and the development of adverse cardiac remodeling.
This chemokine has also been associated as a biomarker for diagnosing Q fever infections.




Interactions


CXCL9 has been shown to interact with CXCR3.




CXCL9 in immune reactions


For immune cell differentiation, some reports show that CXCL9 lead to Th1 polarization through CXCR3. In vivo model by Zohar et al. showed that CXCL9, drove increased transcription of T-bet and RORγ, leading to the polarization of Foxp3− type 1 regulatory (Tr1) cells or T helper 17 (Th17) from naive T cells via STAT1, STAT4, and STAT5 phosphorylation.
Several studies have shown that tumor-associated macrophages (TAMs) play modulatory activities in the TME, and the CXCL9/CXCR3 axis impacts TAMs polarization. The TAMs have opposite effects; M1 for anti-tumor activities, and M2 for pro-tumor activities. Oghumu et al. clarified that CXCR3 deficient mice displayed increased IL-4 production and M2 polarization in a murine breast cancer model, and decreased innate and immune cell-mediated anti-tumor responses.
For immune cell activation, CXCL9 stimulate immune cells through Th1 polarization and activation. Th1 cells produce IFN-γ, TNF-α, IL-2 and enhance anti-tumor immunity by stimulating CTLs, NK cells and macrophages. The IFN-γ-dependent immune activation loop also promotes CXCL9 release.
Immune cells, like Th1, CTLs, NK cells, and NKT cells, show anti-tumor effect against cancer cells through paracrine CXCL9/CXCR3 in tumor models. The autocrine CXCL9/CXCR3 signaling in cancer cells increases cancer cell proliferation, angiogenesis, and metastasis.




CXCL9/CXCR3 and the PDL-1/PD-1


The relationship between CXCL9/CXCR3 and the PDL-1/PD-1 is an important area of research. Programmed cell death-1 (PD-1) shows increased expression on T cells at the tumor site compared to T cells present in the peripheral blood, and anti-PD-1 therapy can inhibit “immune escape” and the immune activation. Peng et al. showed that anti-PD-1 could not only enhance T cell-mediated tumor regression but also increase the expression of IFN-γ but not CXCL9 by bone marrow–derived cells. Blockade of the PDL-1/PD-1 axis in T cells may trigger a positive feedback loop at the tumor site through the CXCL9/CXCR3 axis. Also using anti-CTLA4 antibody, this axis was significantly up-regulated in pretreatment melanoma lesions in patients with good clinical response after ipilimumab administration.




CXCL9 and melanoma


CXCL9 has also been identified as candidate biomarker of adoptive T cell transfer therapy in metastatic melanoma. The role of CXCL9/CXCR3 in TME and immune response - this plays a critical role in immune activation through paracrine signaling, impacting efficacy of cancer treatments.




References






Further reading






External links


Human CXCL9 genome location and CXCL9 gene details page in the UCSC Genome Browser.

Kata Kunci Pencarian:

• Daftar gen penyandi protein pada manusia/1
• CXCL9
• CXCR3
• Mig
• Cytokine storm
• Periodic fever, aphthous stomatitis, pharyngitis and adenitis
• Cell-mediated immunity
• Enadenotucirev
• Chemokine
• Cytokine release syndrome
• Tumor necrosis factor

Artikel Terkait "cxcl9"

CXCL9 - Wikipedia

Chemokine (C-X-C motif) ligand 9 (CXCL9) is a small cytokine belonging to the CXC chemokine family that is also known as monokine induced by gamma interferon (MIG). The CXCL9 is one of the chemokine which plays role to induce chemotaxis, promote differentiation and multiplication of leukocytes, and cause tissue extravasation. [5]

FCXCL - Overview: CXCL9 - Mayo Clinic Laboratories

CXCL9 Aliases. Lists additional common names for a test, as an aid in searching MIG. Monokine Induced by Gamma Interferon. Chemokine (C-X-C motif) ligand 9. CXCL-9. Specimen Type. Describes the specimen type validated for testing Plasma EDTA. Specimen Required. Defines the optimal specimen required to perform the test and the preferred volume ...

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a …

CXCL9, also known as monokine induced by gamma interferon (MIG), is located on human chromosome 4, and is induced by IFN-γ but not by IFN-α/β. CXCL10 and CXCL11 are also located on human chromosome 4. CXCL9 predominantly mediates lymphocytic infiltration to the focal sites and suppresses tumor growth.

CXCL9 Gene - GeneCards | CXCL9 Protein | CXCL9 Antibody

24 Des 2024 · CXCL9 (C-X-C Motif Chemokine Ligand 9) is a Protein Coding gene. Diseases associated with CXCL9 include Proliferative Glomerulonephritis and Paracoccidioidomycosis. Among its related pathways are MIF Mediated Glucocorticoid Regulation …

CXCL9 C-X-C motif chemokine ligand 9 [ (human)] - National …

Gene ID: 4283, updated on 4-Jan-2025. This antimicrobial gene is part of a chemokine superfamily that encodes secreted proteins involved in immunoregulatory and inflammatory processes. The protein encoded is thought to be involved in T cell trafficking.

CXCL9 - an overview | ScienceDirect Topics

CXCL9 is a chemokine that belongs to the alpha or CXC subfamily. It is primarily involved in attracting activated T lymphocytes, particularly of the Th1 phenotype, to sites of inflammation. It is induced by the Th1-associated cytokine IFN-γ and plays a crucial role in regulating effector cell recruitment in Th1-associated diseases.

The role of CXCL family members in different diseases - PMC

CXCL9, CXCL10 and CXCL11 has the same receptor CXCR3. They are secreted by leukocytes, macrophages, tumor cells and fibroblasts. They can be induced by IFN to recruit Th cells, T cells, natural killer cells to perform antiinfection and antitumor role [ 14 ].

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - PubMed

The CXCL9, -10, -11/CXCR3 axis regulates immune cell migration, differentiation, and activation, leading to tumor suppression (paracrine axis). However, there are some reports that show involvements of this axis in tumor growth and metastasis (autocrine axis).

CXCL9-expressing tumor-associated macrophages: new players …

Emerging data suggest that expression of the chemokine CXCL9 by TAMs regulates the recruitment and positioning of CXCR3-expressing stem-like CD8 T (T stem) cells that underlie clinical responses to anti-PD (L)-1 treatment.

CXCL9/10-engineered dendritic cells promote T cell activation …

We evaluate intratumoral (IT) vaccination with CXCL9- and CXCL10-engineered dendritic cells (CXCL9/10-DC) as a strategy to overcome resistance. IT CXCL9/10-DC leads to enhanced T cell infiltration and activation in the TME and tumor inhibition in murine NSCLC models.